These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27685025)

  • 21. Designing clinical trials in amyotrophic lateral sclerosis.
    Shefner JM
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):495-508, ix. PubMed ID: 18625412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALSUntangled 13: Bee venom.
    ALSUntangled Group
    Amyotroph Lateral Scler; 2011 Nov; 12(6):471-2. PubMed ID: 22023191
    [No Abstract]   [Full Text] [Related]  

  • 23. ALSUntangled 51: RCH4.
    ALSUntangled Group
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):150-153. PubMed ID: 31599169
    [No Abstract]   [Full Text] [Related]  

  • 24. ALSUntangled 43: copper.
    ALSUNTANGLED GROUP
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):472-476. PubMed ID: 29191044
    [No Abstract]   [Full Text] [Related]  

  • 25. Amantadine and guanidine are ineffective in ALS.
    Munsat TL; Easterday CS; Levy S; Wolff SM; Hiatt R
    Neurology; 1981 Aug; 31(8):1054-5. PubMed ID: 7022258
    [No Abstract]   [Full Text] [Related]  

  • 26. ALSUntangled no. 25: ursodiol.
    ALSUntangled Group
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):475-8. PubMed ID: 24972316
    [No Abstract]   [Full Text] [Related]  

  • 27. ALSUntangled #72: Insulin.
    Brown A; Armon C; Barkhaus P; Beauchamp M; Bertorini T; Bromberg M; Cadavid JM; Carter GT; Crayle J; Feldman EL; Heiman-Patterson T; Jhooty S; Linares A; Li X; Mallon E; Mcdermott C; Mushannen T; Nathaniel G; Pattee G; Pierce K; Ratner D; Slactova L; Wicks P; Bedlack R
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):416-419. PubMed ID: 38018119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endpoint considerations for clinical trials.
    Walton MK
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S3-6. PubMed ID: 12396791
    [No Abstract]   [Full Text] [Related]  

  • 29. A pilot trial with clenbuterol in amyotrophic lateral sclerosis.
    Sorarù G; Pegoraro E; Spinella P; Turra S; D'Ascenzo C; Baggio L; Mantovan MC; Vergani L; Angelini C
    Amyotroph Lateral Scler; 2006 Dec; 7(4):246-8. PubMed ID: 17127564
    [No Abstract]   [Full Text] [Related]  

  • 30. ALSUntangled 59: Tamoxifen.
    Bedlack R; Kihuwa-Mani S; Barkhaus PE; Bereman M; Caress JB; Crayle J; Pattee GL; Heiman Patterson T; Wicks P; Zach N; Carter GT; Salmon K
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):595-598. PubMed ID: 33474997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
    IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALSUntangled No. 16: cannabis.
    ALSUntangled Group
    Amyotroph Lateral Scler; 2012 Jun; 13(4):400-4. PubMed ID: 22632446
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical development of levetiracetam for amyotrophic lateral sclerosis.
    Davies SL; Moral MA
    Drug News Perspect; 2006 Nov; 19(9):572-3. PubMed ID: 17220961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Dilemma of the Clinical Trialist in Amyotrophic Lateral Sclerosis: The Hurdles to Finding a Cure.
    Katz JS; Barohn RJ; Dimachkie MM; Mitsumoto H
    Neurol Clin; 2015 Nov; 33(4):937-47. PubMed ID: 26515630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALSUntangled No. 47: RT001.
    Bedlack R
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):294-297. PubMed ID: 30689428
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trials in amyotrophic lateral sclerosis: the tenuous past and the promising future.
    Choudry RB; Cudkowicz ME
    J Clin Pharmacol; 2005 Dec; 45(12):1334-44. PubMed ID: 16291708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zeroing in on Amyotrophic lateral sclerosis. A look at a new era of ALS research.
    Health After 50 Sci Am Consum Health; 2015 Dec; 27(12):4-5. PubMed ID: 26685335
    [No Abstract]   [Full Text] [Related]  

  • 38. ALSUntangled 39: Acuscope (micro-Amp electrical muscle stimulation).
    ALSUntangled Group
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):466-469. PubMed ID: 28631960
    [No Abstract]   [Full Text] [Related]  

  • 39. ALSUntangled (ALSU): a scientific approach to off-label treatment options for people with ALS using tweets and twitters.
    Bedlack R; Hardiman O
    Amyotroph Lateral Scler; 2009 Jun; 10(3):129-30. PubMed ID: 19455452
    [No Abstract]   [Full Text] [Related]  

  • 40. Riluzole in amyotrophic lateral sclerosis.
    Murphy JR
    N Engl J Med; 1994 Jul; 331(4):273; author reply 273-4. PubMed ID: 8015580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.